Functional Gastrointestinal Disorders Clinical Trial
Official title:
Effect of Lactobacillus GG on the Appearance of Functional Gastrointestinal Disorders in Children With Cow's Milk Allergy
Cow's milk allergy (CMA) is the most common food allergy in early childhood, with an estimated incidence ranging between 2% and 3% in infants and marginally lower in older children. It has been demonstrated that it could be a risk factor for the development of the functional gastrointestinal disorders in children. Intestinal microflora has been indicated as potential target for the management of CMA and FGDIs through the use of probiotics. Lactobacillus rhamnosus GG (LGG) is the most studied probiotic. Recently, it has been demonstrated that an extensively hydrolyzed casein formula remains hypoallergenic following the addition of LGG, satisfying both the American Academy of Pediatrics guidelines. Lactobacillus GG exerts several benefits when added to an extensively hydrolyzed casein formula (Nutramigen LGG), including decreased severity of atopic dermatitis, improved recovery of intestinal symptoms in infants with CMA-induced allergic colitis, and faster induction of tolerance in infants with CMA. The mechanisms of these effects are multiple and exerted at different levels: epithelium, immune system and enteric nervous system. Studies and meta-analyses showed that LGG increases treatment success in children with functional gastrointestinal disorders.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05936112 -
Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study
|
N/A | |
| Completed |
NCT02565355 -
Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children
|
N/A | |
| Completed |
NCT02657668 -
Emotion Focused Therapy in Irritable Bowel Syndrome Patients
|
N/A | |
| Completed |
NCT02731664 -
GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
|
Phase 1 | |
| Recruiting |
NCT06205446 -
Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction
|
N/A | |
| Recruiting |
NCT05718960 -
Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
|
N/A | |
| Terminated |
NCT04247100 -
A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders
|
N/A | |
| Recruiting |
NCT03625674 -
Impact of Stigma on Compliance to Medication in Functional Dyspepsia
|
N/A | |
| Completed |
NCT03252743 -
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
|
N/A | |
| Recruiting |
NCT05832528 -
Low FODMAP Diet in FD (PDS)
|
N/A | |
| Completed |
NCT02936713 -
Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms
|
N/A | |
| Terminated |
NCT01712412 -
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
|
Phase 2 | |
| Completed |
NCT00564525 -
Study of Medication for Functional Abdominal Pain in Children
|
Phase 4 | |
| Recruiting |
NCT05987813 -
Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation
|
N/A | |
| Completed |
NCT04155801 -
A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances
|
N/A | |
| Recruiting |
NCT05880199 -
BSGM to Evaluate Patients With GI Symptoms
|
||
| Recruiting |
NCT04625881 -
Effects of an Apple Derived Fibre Supplement on Constipation
|
Phase 3 | |
| Completed |
NCT03608735 -
Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
|
||
| Recruiting |
NCT04773158 -
Systematic Pediatric Assessment of Rome Criteria
|
N/A | |
| Completed |
NCT02306369 -
Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents
|
N/A |